The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Edaravone market was valued at US$ 983.4 million in 2023 and is anticipated to reach US$ 1346.7 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
North American market for Edaravone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Edaravone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone.
Report Scope
The Edaravone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Segment by Type
Oral Edaravone
Injection Edaravone
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edaravone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Edaravone market was valued at US$ 983.4 million in 2023 and is anticipated to reach US$ 1346.7 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
North American market for Edaravone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Edaravone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Edaravone include Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Unichem Laboratories Ltd, UCB India Ltd and Piramal Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Edaravone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edaravone.
Report Scope
The Edaravone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edaravone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edaravone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Segment by Type
Oral Edaravone
Injection Edaravone
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Edaravone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Edaravone Market Overview
1.1 Product Overview and Scope of Edaravone
1.2 Edaravone Segment by Type
1.2.1 Global Edaravone Market Value Comparison by Type (2024-2030)
1.2.2 Oral Edaravone
1.2.3 Injection Edaravone
1.3 Edaravone Segment by Application
1.3.1 Global Edaravone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Edaravone Market Size Estimates and Forecasts
1.4.1 Global Edaravone Revenue 2019-2030
1.4.2 Global Edaravone Sales 2019-2030
1.4.3 Global Edaravone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Edaravone Market Competition by Manufacturers
2.1 Global Edaravone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Edaravone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Edaravone Average Price by Manufacturers (2019-2024)
2.4 Global Edaravone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Edaravone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Edaravone, Product Type & Application
2.7 Edaravone Market Competitive Situation and Trends
2.7.1 Edaravone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Edaravone Players Market Share by Revenue
2.7.3 Global Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Edaravone Retrospective Market Scenario by Region
3.1 Global Edaravone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Edaravone Global Edaravone Sales by Region: 2019-2030
3.2.1 Global Edaravone Sales by Region: 2019-2024
3.2.2 Global Edaravone Sales by Region: 2025-2030
3.3 Global Edaravone Global Edaravone Revenue by Region: 2019-2030
3.3.1 Global Edaravone Revenue by Region: 2019-2024
3.3.2 Global Edaravone Revenue by Region: 2025-2030
3.4 North America Edaravone Market Facts & Figures by Country
3.4.1 North America Edaravone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Edaravone Sales by Country (2019-2030)
3.4.3 North America Edaravone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Edaravone Market Facts & Figures by Country
3.5.1 Europe Edaravone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Edaravone Sales by Country (2019-2030)
3.5.3 Europe Edaravone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Edaravone Market Facts & Figures by Country
3.6.1 Asia Pacific Edaravone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Edaravone Sales by Country (2019-2030)
3.6.3 Asia Pacific Edaravone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Edaravone Market Facts & Figures by Country
3.7.1 Latin America Edaravone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Edaravone Sales by Country (2019-2030)
3.7.3 Latin America Edaravone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Edaravone Market Facts & Figures by Country
3.8.1 Middle East and Africa Edaravone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Edaravone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Edaravone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Edaravone Sales by Type (2019-2030)
4.1.1 Global Edaravone Sales by Type (2019-2024)
4.1.2 Global Edaravone Sales by Type (2025-2030)
4.1.3 Global Edaravone Sales Market Share by Type (2019-2030)
4.2 Global Edaravone Revenue by Type (2019-2030)
4.2.1 Global Edaravone Revenue by Type (2019-2024)
4.2.2 Global Edaravone Revenue by Type (2025-2030)
4.2.3 Global Edaravone Revenue Market Share by Type (2019-2030)
4.3 Global Edaravone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Edaravone Sales by Application (2019-2030)
5.1.1 Global Edaravone Sales by Application (2019-2024)
5.1.2 Global Edaravone Sales by Application (2025-2030)
5.1.3 Global Edaravone Sales Market Share by Application (2019-2030)
5.2 Global Edaravone Revenue by Application (2019-2030)
5.2.1 Global Edaravone Revenue by Application (2019-2024)
5.2.2 Global Edaravone Revenue by Application (2025-2030)
5.2.3 Global Edaravone Revenue Market Share by Application (2019-2030)
5.3 Global Edaravone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mitsubishi Tanabe Pharma
6.1.1 Mitsubishi Tanabe Pharma Corporation Information
6.1.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio
6.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.2 Simcere
6.2.1 Simcere Corporation Information
6.2.2 Simcere Description and Business Overview
6.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Simcere Edaravone Product Portfolio
6.2.5 Simcere Recent Developments/Updates
6.3 Taj Pharmaceuticals Ltd.
6.3.1 Taj Pharmaceuticals Ltd. Corporation Information
6.3.2 Taj Pharmaceuticals Ltd. Description and Business Overview
6.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio
6.3.5 Taj Pharmaceuticals Ltd. Recent Developments/Updates
6.4 Sun Pharmaceutical Industries Ltd.
6.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.4.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio
6.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.5 Unichem Laboratories Ltd
6.5.1 Unichem Laboratories Ltd Corporation Information
6.5.2 Unichem Laboratories Ltd Description and Business Overview
6.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Unichem Laboratories Ltd Edaravone Product Portfolio
6.5.5 Unichem Laboratories Ltd Recent Developments/Updates
6.6 UCB India Ltd
6.6.1 UCB India Ltd Corporation Information
6.6.2 UCB India Ltd Description and Business Overview
6.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 UCB India Ltd Edaravone Product Portfolio
6.6.5 UCB India Ltd Recent Developments/Updates
6.7 Piramal Healthcare
6.6.1 Piramal Healthcare Corporation Information
6.6.2 Piramal Healthcare Description and Business Overview
6.6.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Piramal Healthcare Edaravone Product Portfolio
6.7.5 Piramal Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Edaravone Industry Chain Analysis
7.2 Edaravone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Edaravone Production Mode & Process
7.4 Edaravone Sales and Marketing
7.4.1 Edaravone Sales Channels
7.4.2 Edaravone Distributors
7.5 Edaravone Customers
8 Edaravone Market Dynamics
8.1 Edaravone Industry Trends
8.2 Edaravone Market Drivers
8.3 Edaravone Market Challenges
8.4 Edaravone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
